工业大麻股盘前再度上涨，特朗普据报最早本周签行政命令放宽大麻类管制

Core Viewpoint - Industrial hemp stocks have seen a pre-market surge, with notable increases in companies such as CbdMD, Canopy Growth, and Tilray Brands, following reports of an impending executive order from President Trump to ease cannabis classification regulations and recognize its medical use at the federal level [1] Group 1: Market Reactions - CbdMD shares rose nearly 14% in pre-market trading [1] - Canopy Growth shares increased by over 7% [1] - Tilray Brands shares saw a nearly 2% rise [1] Group 2: Executive Order Details - President Trump is expected to sign an executive order as early as this week to relax cannabis classification regulations [1] - The order may direct the Drug Enforcement Administration or the Department of Justice to issue final regulations reclassifying cannabis from a Schedule I substance to Schedule III [1] - The executive order could also instruct Congress to pass legislation allowing legal cannabis businesses access to major banking and financial services [1] Group 3: Healthcare Implications - The executive order may direct the Centers for Medicare & Medicaid Services to allow reimbursement for cannabidiol (CBD) products under Medicare [1]